RecruitingNCT07162038
Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
PHASE1 · 155 planned enrolment
- Countries listed
- 1
- Registry update
- September 21, 2026
